|
Volume 271, Number 37,
Issue of September 13, 1996
pp. 22398-22406
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Calcium-dependent, Interleukin 1 -converting
Enzyme Inhibitor-insensitive Degradation of Lamin B1
and DNA Fragmentation in Isolated Thymocyte Nuclei*
(Received for publication, April 9, 1996, and in revised form, June 18, 1996)
David J.
McConkey
From the Department of Cell Biology, The University of Texas
M. D. Anderson Cancer Center, Houston, Texas 77030
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Recent work suggests that the proteolytic
degradation of the nuclear lamins is a common event in apoptosis,
although the nature of the proteases involved is still not clear. Our
previous work showed that the degradation of lamin B1 in
glucocorticoid-treated thymocytes occurs via a
Ca2+-sensitive mechanism and that exogenous
Ca2+ promotes lamin degradation in isolated thymocyte
nuclei from untreated cells. Here we demonstrate that peptide-based
inhibitors of the interleukin 1 -converting enzyme family of cysteine
proteases (Tyr-Val-Ala-Asp fluoromethyl ketone) and of the nuclear
scaffold multicatalytic proteinase (Ala-Pro-Phe chloromethyl ketone)
block the degradation of lamin B1 to a 21-kDa fragment in
thymocytes treated with glucocorticoid, the Ca2+-mobilizing
agent thapsigargin, or antibodies to the T cell receptor. However,
among a panel of inhibitors specific for several different proteases
implicated in apoptosis, only tosylphenylalanyl chloromethyl ketone and
the nuclear scaffold protease inhibitor block lamin degradation,
histone H1 cleavage, and DNA fragmentation in isolated thymocyte nuclei
incubated with Ca2+. Overexpression of human BCL-2 in
nuclei by stable transfection resulted in an inhibition of
Ca2+-stimulated lamin degradation and DNA fragmentation,
suggesting that endogenous nuclear BCL-2 regulates activation of the
nuclear scaffold protease. The results demonstrate the existence of an
alternative pathway of lamin degradation and DNA fragmentation mediated
by a resident Ca2+-stimulated nuclear protease that is not
directly dependent upon activation of the interleukin 1 -converting
enzyme family of cell death regulators.
INTRODUCTION
Apoptosis is a process of physiological cell death characterized
by a series of stereotyped morphological alterations and endogenous
endonuclease activation leading to the generation of large (50 kb1) and oligonucleosomal DNA fragments (1,
2). Although inhibitors of macromolecular synthesis prevent apoptosis
in many circumstances, it is currently thought that the essential
enzymatic components of the effector pathway are constitutively
expressed in all mammalian cells beyond the blastomere stage of
embryonic development (3). The identities of these cell death mediators
are currently not known, but a major recent breakthrough toward their
identification has come from work on the genes that regulate programmed
cell death in the nematode Caenorhabditis elegans (4). This
work has revealed that the C. elegans death promoter
ced-3 is structurally homologous to a growing family of
proteins related to human interleukin 1 -converting enzyme (ICE) (5),
a cysteine protease. Subsequent research has shown that specific viral
and peptide-based inhibitors of the ICE family block apoptotic cell
death in many mammalian models (4, 5, 6, 7, 8, 9), indicating that ICE and its
homologs play crucial roles in the effector phase of apoptosis.
Recent work has shown that the nuclear lamins are cleaved by one or
more members of the ICE family during apoptosis. Early work by Kaufmann
(10) demonstrated that the oligonucleosomal DNA fragmentation induced
by cancer chemotherapeutic agents in a human myelogenous leukemia line
(HL-60) was associated with the degradation of lamin B1
(and several other nuclear polypeptides). Subsequent work has shown
that lamin degradation is associated with DNA fragmentation and cell
death in several other models of apoptosis (11, 12, 13, 14) and with chromatin
condensation and endonuclease activation in isolated nuclei incubated
with apoptosis-promoting cell extracts (14, 15) or Ca2+
(11). The identities of the lamin proteases are not known, although
preliminary evidence suggests that an ICE family member may be directly
involved (15), and a Ca2+-dependent serine
protease exhibiting ``chymotrypsin-like'' activity that is associated
with the nuclear scaffold (NS) has been implicated in another (16). A
direct role for lamin degradation in chromatin condensation and DNA
fragmentation is attractive, as lamin solubilization is associated with
chromatin condensation in both apoptosis and mitosis, the spacing of
lamin binding sites in chromatin (periodicity of approximately 20-50
kb) mirrors the sizes of large DNA fragments produced at the commitment
phase of apoptosis (17, 18, 19, 20, 21), and the kinetics of lamin degradation and
50-kb DNA fragment formation overlap (11).
Much of our previous work has been concerned with identifying the
biochemical mechanisms that regulate endogenous endonuclease activation
and cell death in immature thymocytes undergoing apoptosis in response
to a variety of stimuli. We have shown that early, sustained increases
in the cytosolic Ca2+ concentration are commonly involved,
and Ca2+ buffering agents can interfere with endonuclease
activation and cell death (22). It is possible that these
Ca2+ alterations exert direct effects on components of the
apoptotic effector machinery resident in the nucleus, as a number of
investigators have demonstrated that typical morphological alterations
and chromatin cleavage can be induced in isolated nuclei from untreated
cells upon incubation in the presence of exogenous Ca2+
(23, 24, 25, 26, 27). However, to date the proteases responsible for
Ca2+-dependent lamin cleavage in apoptotic
cells and isolated nuclei have not been characterized, nor has the
possible interrelationship between protease activation and DNA
fragmentation been defined. To address these issues was the aim of the
present study.
EXPERIMENTAL PROCEDURES
Cells and Reagents
Thymocyte suspensions prepared from
4-8-week-old BALB/c mice were maintained in RPMI 1640 medium
supplemented with 10% fetal calf serum, antibiotics, and 50 µM 2-mercaptoethanol. The T-T hybridoma 2B4.11 was
maintained in the RPMI 1640 medium described. Transfectants were
generated by electroporation at 100 V and 800 microfarads using 1 × 107 2B4.11 cells and 10 µg of a linearized plasmid
containing human bcl-2 under the control of the SV40
promoter/enhancer (Bil2-Neo; generously provided by Dr. Timothy
McDonnell, The University of Texas M. D. Anderson Cancer Center).
Cells were then selected for 2 weeks in the presence of 0.4 mg/ml G418
(Geneticin, Life Technologies, Inc.), and BCL-2 expression in the
resistant cells was verified by immunoblotting with the anti-human
BCL-2 monoclonal antibody 6C8. The metastatic murine melanoma line
K1735 clone M2X21 was maintained in modified Eagle's medium
supplemented with 10% fetal calf serum, vitamins, and sodium pyruvate.
Transfectants were generated by calcium phosphate precipitation using
the Bil2-Neo plasmid as described previously (28). Cells were then
selected for 3 weeks in the presence of 0.4 mg/ml G418, and BCL-2
expression in resistant colonies was determined by immunoblotting.
Viability was assessed by trypan blue exclusion.
Peptide inhibitors of ICE (YVADfmk, zVADfmk, based on a cleavage site
in interleukin-1 ) and CPP32 (DEVDfmk, based on a cleavage site in
PARP) were purchased from Enzyme Systems Products, Inc. (Dublin, CA).
Another peptide inhibitor of ICE (YVADcmk) and an inhibitor of the NS
protease (APFcmk) were from Bachem (King of Prussia, PA). All other
inhibitors were purchased from Sigma.
Isolation of Nuclei
Cells were lysed in 0.1% Nonidet P-40
and nuclei isolated by centrifugation at 200 × g
through a glycerol cushion as described previously (11). Nuclei were
washed twice in incubation buffer (150 mM KCl, 5 mM MgCl2, 25 mM Tris, pH 7.5) and
resuspended in the same buffer for incubation. The purity of
representative preparations from each cell type was verified by
electron microscopy.
DNA Fragmentation Analysis
Quantification of DNA
fragmentation was accomplished using the diphenylamine reagent as
described previously (29). Briefly, cells were harvested by
centrifugation, lysed in 0.5 ml of a buffer containing 0.5% Triton
X-100, 25 mM Tris, pH 8.0, 10 mM EGTA, and 10 mM EDTA for 15 min on ice, and samples were centrifuged for
20 min at 12,000 × g to separate DNA fragments
(supernatants) from intact chromatin (pellets). The DNA content in each
fraction was determined using the diphenylamine reagent (30); results
are expressed as the percentage of total DNA in each sample which
resisted sedimentation at 12,000 × g. Alternatively,
the DNA present in the centrifuged supernatants was precipitated
overnight at 20 °C following the addition of 2 volumes of
isopropyl alcohol and NaCl (to 0.5 M final concentration).
After centrifugation at 12,000 × g for 10 min,
precipitates were harvested, dried, and incubated for 1 h in TE
buffer (10 mM Tris, pH 8.0, 1 mM EDTA)
containing 0.2 mg/ml proteinase K and 1 mg/ml RNase A. The DNA
fragments were resolved by electrophoresis for 1 h at 75 V on
1.5% agarose gels preimpregnated with ethidium bromide. The DNA
fragments were then photographed.
Field-inversion gel electrophoresis (FIGE) (FIGE mapper, Bio-Rad) was
used to detect large DNA fragments. Aliquots of nuclei were mixed with
equal volumes of a melted plug solution containing 150 mM
NaCl, 10 mM Tris, pH 7.5, 10 mM EDTA, and 1.2%
low melting point agarose, transferred to wells of a FIGE plug mold,
and incubated for 15 min at 4 °C. Plugs were then ejected and
incubated for 16 h at 37 °C in a lysis buffer containing 50 mM Tris, pH 8.0, 50 mM EDTA, 1% sarcosyl, and
0.2 mg/ml proteinase K. Plugs were then washed three times for 1 h
at 4 °C in a buffer containing 10 mM Tris and 1 mM EDTA, and the plugs were inserted into the wells of a
1% agarose gel. DNA fragments were then resolved by FIGE at a forward
voltage of 180 V and a reverse voltage of 120 V for 16 h using a
switch time ramp of 0.1-3.5 s (program 4 provided by the
manufacturer). Gels were then stained with ethidium bromide and
photographed.
Immunoblotting
Cells were lysed for 5 min at 37 °C and
rotated for 1 h at 4 °C in a stringent lysis buffer containing
150 mM NaCl, 1% Triton X-100, 0.5% sodium dodecyl sulfate
(SDS), 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl
fluoride, and 25 mM Tris, pH 7.5 (lamin B1 and
histone H1 experiments) or for 1 h at 4 °C in the same buffer
lacking SDS and sodium deoxycholate (BCL-2 experiments). Debris was
pelletted by centrifugation for 5 min at 12,000 × g,
and pellets and/or supernatants were solubilized for 5 min at 100 °C
in Laemmli's SDS-polyacrylamide gel electrophoresis sample buffer
containing 100 mM dithiothreitol. Polypeptides were
resolved at 100 V on 12% gels and electrophoretically transferred to
nitrocellulose (0.2 µm, Schleicher & Schuell) for 1 h at 100 V. Membranes were blocked overnight (lamin experiments) or for 2 h
(histone H1 and BCL-2 experiments) in a Tris-buffered saline solution
containing Tween 20 (TBS-T) (25 mM Tris, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 3% (w/v) nonfat
dried milk. To detect lamin B1, membranes were probed for
2 h with the chicken anti-lamin B1 antibody (1/5000 in
TBS-T), 1 h with rabbit anti-chicken Ig (1/2000 in TBS-T), and
1 h with donkey anti-rabbit Ig (1/2000 in TBS-T) and then
developed by enhanced chemiluminescence (ECL) (Amersham Corp.)
according to the manufacturer's instructions. To detect histone H1,
membranes were probed overnight with a mouse monoclonal antibody to
histone H1 (Biogenex Inc., 1/1000 in block) and 1 h with sheep
anti-mouse Ig (1/2000 in TBS-T) and developed by ECL. To detect human
BCL-2, membranes were blocked overnight, probed for 1 h with 6C8
(1 µg/ml in TBS-T), 1 h with rabbit anti-hamster Ig (1/2000 in
TBS-T), and 1 h with donkey anti-rabbit Ig (1/2000 in TBS-T) and
developed by ECL.
RESULTS
Previous work using specific peptide-based protease inhibitors has
implicated two distinct proteases (ICE family members and the
Ca2+-dependent NS protease) in the cleavage of
lamin B1 in apoptotic cells and in a cell-free system. We
therefore tested the effects of these peptide inhibitors on lamin
B1 cleavage and DNA fragmentation in thymocytes induced to
undergo apoptosis upon exposure to glucocorticoid, the
Ca2+-mobilizing agent thapsigargin, and antibodies to the T
cell receptor complex. The peptide inhibitor of ICE, YVADfmk (7, 8, 9,
31), effectively inhibited lamin B1 cleavage in response to
all three stimuli (Fig. 1A) and partially
prevented both spontaneous and induced DNA fragmentation in the cells
(Fig. 1, B and C). However, a peptide inhibitor
of the NS protease, APFcmk (16), was even more potent, completely
blocking lamin cleavage (Fig. 1A) and DNA fragmentation
(Fig. 1, B and C) in all circumstances. Both
inhibitors also exerted corresponding effects on the decrease in cell
size normally associated with apoptosis in thymocytes (measured by
forward scatter by fluorescence-activated cell sorter, not shown) and
cell death (Fig. 1D). Together, these results confirm other
recent findings indicating that peptide inhibitors of the ICE family
(31, 32) or the NS protease (32) interfere with all of the biochemical
events of apoptosis in whole thymocytes that are exposed to certain
apoptotic stimuli.
Fig. 1.
Inhibition of lamin cleavage, DNA
fragmentation, and cell death by peptide protease antagonists in whole
thymocytes. Panel A, lamin cleavage. Cells were incubated
for 5 h in the absence or presence of 25 µM YVADfmk
or 25 µM APFcmk with or without 10 µM
methylprednisolone (MPS), 100 nM thapsigargin,
or 10 µg/ml anti-CD3 (145.2C11) plus 10 µg/ml anti-CD4 (Gk1.5) and
species-specific cross-linkers, and proteolysis of lamin B1
was analyzed by immunoblotting. Panel B, cells were
incubated as outlined in panel A, and DNA fragmentation was
quantified using the diphenylamine reagent. Mean ± S.D.,
n = 3. White bars, medium alone; black
bars, +YVADfmk; striped bars, +APFcmk. Panel
C, qualitative analysis of DNA fragmentation. Cells were incubated
in the presence or absence of the peptide protease antagonists with or
without 10 µM methylprednisolone, and DNA fragmentation
was analyzed by agarose gel electrophoresis. Panel D, loss
of plasma membrane integrity. Bars as in panel
B.
[View Larger Version of this Image (47K GIF file)]
Recently, several groups have used different cell-free systems to study
the regulation of various components of the apoptotic effector
machinery (7, 14, 33, 34). However, we and others have shown that
glucocorticoids, thapsigargin, and T cell receptor triggering all
induce apoptosis in thymocytes via mechanisms that involve alterations
in intracellular Ca2+ homeostasis (22) and that exogenous
Ca2+ can directly promote the nuclear changes of apoptosis
in isolated nuclei in the absence of cytoplasm (11, 18, 24, 27, 35).
Moreover, it has been suggested that Ca2+-mediated DNA
fragmentation involves unidentified serine proteases constitutively
present in isolated rat liver nuclei (36). We therefore investigated
the involvement of various proteases in DNA fragmentation observed in
nuclei incubated with Ca2+. Preliminary work demonstrated
that exogenous Ca2+ promoted DNA fragmentation in isolated
thymocyte nuclei in a dose-dependent fashion (Fig.
2A). The response was characterized by the
formation of both large 30-50-kb (Fig. 2B) and
oligonucleosomal (not shown) DNA fragments. Similarly, Ca2+
promoted the cleavage of lamin B1 to a distinct fragment of
roughly 21 kDa (Fig. 2C) and the solubilization and cleavage
of histone H1 (Fig. 2D) over a similar dose range.
Fig. 2.
Dose-dependent effects of
Ca2+ on endonuclease activation and proteolysis of
chromatin-associated proteins in isolated thymocyte nuclei. Panel
A, quantification of DNA fragmentation. Isolated nuclei were
incubated in the presence of the indicated concentrations of
Ca2+ for 2 h, and DNA fragmentation was quantified
using the diphenylamine reagent. Mean ± S.D., n = 4. Panel B, effects on large DNA fragment formation. Nuclei
were incubated with the indicated concentrations of Ca2+
for 1 h, and the presence of 50-kb DNA fragments was determined by
FIGE. Panel C, Effects on cleavage of lamin B1.
Isolated nuclei were incubated for 1 h in the presence of the
indicated concentrations of Ca2+, and lamin proteolysis was
assessed by immunoblotting. Panel D, effects on
solubilization of histone H1. Nuclei were incubated in the
indicated concentrations of Ca2+ for 2 h, and histone
H1 solubilization and cleavage were assessed by
immunoblotting as detailed under ``Experimental Procedures.''
[View Larger Version of this Image (45K GIF file)]
The observation that Ca2+ promoted the solubilization and
cleavage of both lamin B1 and histone H1 suggested that
activation of endogenous nuclear proteases was associated with
Ca2+-stimulated DNA fragmentation in isolated thymocyte
nuclei. We therefore employed a panel of protease inhibitors to
characterize further the activities involved. Two different calpain
inhibitors, the serine protease inhibitor TLCK and YVADfmk both failed
to affect DNA fragmentation (Fig. 3, A and
B), lamin B1 cleavage (Fig. 3C), or
histone H1 solubilization and cleavage (Fig. 3D). Similarly,
another peptide-based ICE family antagonist, DEVDfmk (37), had no
effect on Ca2+-mediated proteolysis or DNA fragmentation in
isolated thymocyte nuclei over a wide dose range (1-200
µM, not shown). The only two inhibitors that were
effective in this system were the serine protease antagonist TPCK and
the NS protease antagonist APFcmk, which blocked all of the
Ca2+-induced biochemical events (Fig. 3) in a
dose-dependent fashion (Fig. 4). Thus, a
protease sensitive to TPCK and APFcmk, but insensitive to ICE family
and calpain antagonists, is required for Ca2+-mediated
lamin B1 and histone H1 solubilization and cleavage and for
endonuclease activation in isolated thymocyte nuclei.
Fig. 3.
Effects of various protease inhibitors on DNA
fragmentation and lamin cleavage in isolated nuclei. Panel
A, quantitative comparison. Isolated nuclei were incubated for
2 h with or without 5 mM Ca2+ in the
absence or presence of 100 µM calpain inhibitor I
(CP I), TLCK, TPCK, YVADfmk, or APFcmk, and DNA fragmentation was
quantified using the diphenylamine reagent. Mean ± S.D.,
n = 3. Panel B, effects on oligonucleosomal
DNA fragmentation. Isolated nuclei were incubated as described in
panel A, and the presence of oligonucleosomal DNA
fragmmentation was determined by agarose gel electrophoresis.
Panel C, effects on cleavage of lamin B1.
Isolated nuclei were incubated for 1 h with or without 5 mM Ca2+ in the absence or presence of 100 µM calpain inhibitor I, 100 µM TLCK, 100 µM YVADfmk, 100 µM TPCK, 100 µM APFcmk, 25 µM calmidizolium, 1 mM ATA, or 0.5 mM Zn2+, and lamin
proteolysis was measured by immunoblotting. Panel D, effects
on histone H1 solubilization and cleavage. Isolated nuclei were
incubated with or without 5 mM Ca2+ in the
absence or presence of 100 µM calpain inhibitor I, 100 µM TLCK, 100 µM TPCK, or 100 µM YVADfmk, and histone H1 was detected by
immunoblotting.
[View Larger Version of this Image (19K GIF file)]
Fig. 4.
Dose-dependent effects of the
phenylalanine-containing protease antagonists on DNA
fragmentation and lamin cleavage. Panel A, effects
of TPCK on 50-kb DNA fragmentation. Isolated nuclei were
incubated with or without 5 mM Ca2+ in the
presence of the indicated concentrations of TPCK, and DNA fragmentation
was analyzed by FIGE. Panel B, effects of APFcmk on 50-kb
DNA fragmentation. Isolated nuclei were incubated with or without 5 mM Ca2+ in the presence of the indicated
concentrations of APFcmk, and DNA fragmentation was analyzed by FIGE.
Panel C, effects on cleavage of lamin B1.
Isolated nuclei were incubated in the absence or presence of 5 mM Ca2+ and the indicated concentrations of
TPCK or APFcmk, and proteolysis of lamin B1 was measured by
immunoblotting.
[View Larger Version of this Image (63K GIF file)]
Previous work has shown that the nuclease inhibitors aurintricarboxylic
acid (ATA) and Zn2+, are capable of inhibiting DNA
fragmentation and cell death in thymocytes undergoing apoptosis (38)
and can interfere with Ca2+-induced DNA fragmentation in
isolated nuclei (18, 26, 36). However, whether these agents directly
inhibit endonuclease activation or whether they interfere with the
protease activation required for endonuclease activation has not been
established. Incubation with a concentration of Zn2+ which
blocks apoptosis in whole thymocytes (26) did not prevent the cleavage
of lamin B1, whereas ATA partially prevented the response
(Fig. 3C). The nuclease inhibitor ATA also partially
inhibited large DNA fragment formation (Fig.
5A) and largely inhibited oligonucleosomal
DNA fragmentation (Fig. 5B), consistent with previous
observations. Interestingly, submillimolar concentrations of
Zn2+ totally abrogated formation of both the large and
oligonucleosomal DNA fragments (Fig. 5, A and B),
whereas at no dose did Zn2+ inhibit lamin B1
cleavage (Fig. 5C). Together, these observations suggest
that the effects of ATA on large fragment formation may be caused in
part by inhibition of the Ca2+-stimulated NS protease, but
the effects of Zn2+ can be dissociated from NS protease
inhibition and in this system may be linked solely to effects on
nuclease activation.
Fig. 5.
Effects of nuclease inhibitors on DNA
fragmentation and lamin proteolysis. Panel A, effects on
50-kb DNA fragmentation. Isolated nuclei were incubated for 1 h
with or without 5 mM Ca2+ in the absence or
presence of the indicated concentrations of ATA or Zn2+,
and DNA fragmentation was assessed by FIGE. Panel B,
quantitative analysis. Isolated nuclei were incubated for 2 h with
or without 5 mM Ca2+ and the indicated
concentrations of ATA ( ) or Zn2+ ( ), and DNA fragmentation was quantified using the diphenylamine reagent.
Mean ± S.D., n = 3. Panel C,
dose-dependent effects of Zn2+ on lamin
cleavage. Isolated nuclei were incubated for 1 h with or without 5 mM Ca2+ in the absence or presence of the
indicated concentrations of Zn2+, and proteolysis of lamin
B1 was measured by immunoblotting.
[View Larger Version of this Image (23K GIF file)]
Previous work has shown that calmodulin antagonists are capable of
inhibiting DNA fragmentation in thymocytes exposed to apoptotic
triggers (29, 39), and it has been suggested that the NS protease may
be regulated by calmodulin (40). We therefore tested the effects of the
calmodulin antagonist calmidizolium on DNA fragmentation and lamin
B1 cleavage in isolated nuclei. Calmidizolium blocked
Ca2+-induced oligonucleosomal DNA fragmentation in a
dose-dependent fashion (Fig. 6A);
however, it failed to prevent cleavage of lamin B1
(Fig. 6B) or the accumulation of 30-50-kb DNA
fragments (Fig. 6C).
Fig. 6.
Effects of a calmodulin antagonist on DNA
fragmentation and lamin proteolysis in isolated nuclei. Panel
A, effects on oligonucleosomal DNA fragmentation. Isolated nuclei
were incubated for 2 h with or without 5 mM
Ca2+ in the presence of the indicated concentrations of
calmidizolium, and DNA fragmentation was assessed by agarose gel
electrophoresis. Panel B, effects on 50-kb DNA
fragmentation. Isolated nuclei were incubated for 1 h with or
without 5 mM Ca2+ in the presence of the
indicated concentrations of calmidizolium, and DNA fragmentation was
measured by FIGE. Panel C, effects on cleavage of lamin
B1. Isolated nuclei were incubated for 1 h with or
without 5 mM Ca2+ in the presence of the
indicated concentrations of calmidizolium, and proteolysis of lamin
B1 was determined by immunoblotting.
[View Larger Version of this Image (24K GIF file)]
Members of the BCL-2 family play evolutionarily conserved roles in
regulating apoptotic cell death, although the points at which they act
within the pathway remain unclear, as effects of BCL-2 upstream and
downstream (33, 34) of ICE family protease activation have been
suggested. Recent efforts from our laboratory and others have
demonstrated that a significant fraction of total cellular BCL-2
protein is localized to the nuclear envelope (28, 41, 42), and we have
demonstrated that overexpression of BCL-2 can block
Ca2+-stimulated oligonucleosomal DNA fragmentation in
isolated nuclei from a Ras-transformed murine fibroblast line (28). To
investigate further the effects of BCL-2 on the nuclear events of
apoptosis, we transfected the T cell hybridoma 2B4.11, an extensively
characterized cell line that responds to apoptotic triggers in fashion
similar to thymocytes (43), with human BCL-2. Our choice of this line
was reinforced by a recent report confirming that isolated nuclei from
the parental line contain up to three polypeptides (49, 47, and 45 kDa)
termed inducible Ca2+/Mg2+ lymphocyte
endonuclease, which exhibit Ca2+-dependent
nuclease activity inhibitable by Zn2+ (44). Expression of
BCL-2 in whole cells was confirmed by immunoblotting (not shown), and
preliminary experiments confirmed that the cells were resistant to
induction of apoptosis in response to glucocorticoid or thapsigargin
(Fig. 7, A and B). Consistent with
previous studies, isolated nuclei from these cells contained
substantial levels of human BCL-2 (Fig. 7C). Strikingly,
incubation of nuclei from the BCL-2 transfectants in the presence of
Ca2+ failed to stimulate lamin cleavage (Fig.
7D) or DNA fragmentation (Fig. 7E) for up to
2 h, although both responses were observed after longer times of
incubation (not shown). To test whether the effects of BCL-2 were cell
type-specific, we conducted analogous experiments with isolated nuclei
from pooled BCL-2 transfectants of a metastatic murine melanoma line
(K1735 clone M2X21) (45). Again, Ca2+-mediated cleavage of
lamin B1 and DNA fragmentation were dramatically reduced in
nuclei from the BCL-2 transfectants compared with the levels observed
in nuclei from the parental cells (Fig. 7, D and
E). Thus, suppression of
Ca2+-dependent protease activation appears to
represent one important aspect of BCL-2 function in the nucleus that
may explain, at least in part, its effects on the
Ca2+-sensitive pathway of endonuclease activation.
Fig. 7.
Effects of overexpression of BCL-2 in two
different transfectants. Panel A, effects of glucocorticoid
and thapsigargin on the viability of 2B4.11 (white bars) and
2B4/BCL2.1 (black bars) cells. Cells were incubated for
16 h in the absence or presence of 100 nM thapsigargin
or 10 µM methylprednisolone (MPS), and cell
viability was measured by trypan blue exclusion. Mean ± S.D.,
n = 3. Panel B, inhibition of DNA
fragmentation by BCL-2 in whole cells. Cells were incubated in the
absence or presence of 100 nM thapsigargin for 8 h,
and DNA fragmentation was analyzed by agarose gel electrophoresis.
Results are characteristic of three independent experiments.
Panel C, expression of BCL-2 in isolated nuclei detected by
immunoblotting. Panel D, inhibition of
Ca2+-stimulated lamin cleavage by BCL-2. Isolated nuclei
were incubated with or without 5 mM Ca2+ for
1 h, and the p21 fragment of lamin B1 was detected by
immunoblotting. Panel E, inhibition of
Ca2+-stimulated DNA fragmentation by BCL-2. Isolated nuclei
from 2B4.11 (white bars) or 2B4/BCL2.1 cells (black
bars) were incubated for 2 h in the absence or presence of 5 mM Ca2+, and DNA fragmentation was quantified
using the diphenylamine reagent. Mean ± S.D., n = 3.
[View Larger Version of this Image (32K GIF file)]
DISCUSSION
Previous work has shown that lamin degradation is associated with
apoptosis in several different model systems. In this study, we
investigated the nature of the proteases responsible for this event in
whole thymocytes exposed to several different apoptotic stimuli and in
isolated nuclei incubated with exogenous Ca2+. The results
indicate that specific peptide-based inhibitors of the ICE family
(YVADfmk) and of the NS protease (APFcmk) blocked lamin cleavage, DNA
fragmentation, and cell death in whole cells following T cell receptor
triggering or treatment with glucocorticoid or the intracellular
Ca2+-mobilizing agent thapsigargin. Because the NS protease
inhibitor was significantly more potent than the ICE antagonist in
blocking both lamin cleavage and DNA fragmentation, it is possible that
APFcmk affects a process downstream of the ICE family in the pathway of
apoptosis in thymocytes. Consistent with this notion, of a panel of
inhibitors specific for several different proteases which were
implicated previously in apoptosis, only the serine protease inhibitor
TPCK and the NS protease-specific peptide APFcmk blocked lamin
degradation and DNA fragmentation in isolated thymocyte nuclei that
were incubated with Ca2+. Because both compounds possess a
phenylalanine residue proximal to the chloromethyl ketone
derivative (the position that determines inhibitor selectivity), it
appears likely that both compounds affect the same protease in nuclei.
Identifying this protease will be the subject of our future
investigation.
Our results confirm other work indicating that a TPCK-sensitive
protease is required for Ca2+-mediated endonuclease
activation in whole cells and isolated nuclei (36, 46). Although the
nature of this interaction between proteases and endonucleases in the
apoptotic pathway is still not known, the present results support a
hypothetical scenario (18) in which
Ca2+-dependent activation of the NS protease
promotes the degradation of the chromatin-associated polypeptides lamin
B1 and histone H1, resulting in the sequential exposure of
the lamin binding sites and internucleosomal regions to a
Ca2+-dependent endonuclease. Because the lamin
binding sites are spaced every 20-50 kb and the histone H1 attachment
sites every 180 bases in chromatin, this model would account for the
stepwise pattern of DNA cleavage observed in apoptotic thymocytes and
other cell types. From these data it might be postulated that chromatin
cleavage is mediated by a constitutively active endonuclease whose
action is restricted solely by DNA accessibility. However, this idea
does not appear to be correct, as Zn2+ preferentially
blocks the production of both large and oligonucleosomal DNA fragments
without interfering detectably with proteolysis of lamin
B1. Conversely, Lazebnik and colleagues (15) have shown
that it is possible to inhibit lamin degradation without blocking
oligonucleosomal DNA fragmentation with ICE antagonists in nuclei
incubated with cytoplasmic extracts from cells arrested at the S and M
phases of the cell cycle (S/M extracts). Moreover, our results support
the idea suggested by Sun and Cohen (20) that independent endonuclease
activities are responsible for the 50-kb and oligonucleosomal DNA
fragments, as we have found that formation of the latter but not the
former is blocked by calmodulin antagonists in isolated nuclei. In
addition to removing chromatin-bound proteins, it is possible that
proteolytic processing directly affects endonuclease activation, an
idea that is supported by preliminary work suggesting that two
candidate Ca2+-dependent thymocyte
endonucleases appear to exist as high molecular weight precursors in
untreated cells (47, 48), and it may account for the appearance of the
47- and 45-kDa inducible Ca2+/Mg2+ lymphocyte
endonuclease polypeptides in isolated nuclei from 2B4.11 cells exposed
to glucocorticoid or anti-T cell receptor antibodies prior to the onset
of apoptosis (44).
The nuclear localization, Ca2+-dependence, and peptide
inhibitor sensitivity of the protease implicated in lamin cleavage and
DNA fragmentation in this study are all specific characteristics of the
NS protease. Although most of the molecular characteristics of this
protease are still not known, preliminary work indicates that it is
structurally related to the multicatalytic proteinase complex,
otherwise known as the proteosome (16). The observation that elevations
in the cytosolic Ca2+ concentration trigger chromatin
condensation and nuclear envelope breakdown during mitosis (49, 50)
coupled with the ability of cytosolic Ca2+ increases to
activate the NS protease directly (16) raises the possibility that the
NS protease is not only involved in certain examples of apoptosis but
also in some aspects of mitosis. Circumstantial support for this
hypothesis is provided by the observation that disregulated
proliferation in hyperplastic nodules and hepatocellular carcinomas is
associated with elevated NS protease activity (51, 52), and a peptide
inhibitor of the NS protease blocks chemical transformation in a murine
fibroblast line (53). Coordinate regulation of catabolic enzymes in
apoptosis and mitosis is an attractive possibility given the observed
similarities in cellular morphology as well as the known capacity of
oncogenes (most notably Myc) (54) and cyclin-dependent
kinases (55) to promote both responses. It is also possible that the
proteosome itself may play some role in the cytoplasmic events of
apoptosis, as increases in ubiquitin expression (56) and in enhanced
ubiquitination of cellular proteins (57) are linked to programmed cell
death in the moth Manduca sexta and in irradiated human
peripheral blood lymphocytes, respectively.
Recently, a number of investigators have used cell-free systems in an
attempt to identify the biochemical machinery necessary for the nuclear
features of apoptosis. These studies were initiated by Lazebnik and
co-workers (14), who demonstrated that S/M extracts were capable of
inducing characteristic chromatin condensation, nuclear lamina
disruption, and DNA fragmentation in isolated nuclei from control
cells. Importantly, lamin degradation and endonuclease activation in
nuclei incubated with S/M extracts (and other cell-free systems)
occurred in the absence of exogenous Ca2+ (14), and lamin
degradation and DNA fragmentation were insensitive to TPCK and the
peptide inhibitor of the NS protease (15). Together with the results
reported here, these data indicate that there are at least two pathways
to lamin degradation and DNA fragmentation in isolated nuclei, one
mediated by activated ICE family members and the other by
Ca2+-induced activation of the NS protease. It is still
formally possible that the ICE pathway activates one of the
Ca2+-independent enzymatic activities of the NS protease,
an issue that requires further investigation.
Despite intensive investigation, the mechanisms underlying the
inhibition of apoptosis by BCL-2 are still not clear. In this study, we
demonstrated that the amount of BCL-2 constitutively present in
isolated nuclei from two divergent cell lines transfected with BCL-2 is
sufficient to block Ca2+-mediated lamin degradation and DNA
fragmentation. Precisely how it does so is not known, although we have
recently obtained evidence that BCL-2 may exert its effects, at least
in part, via its action on an energy-dependent
Ca2+ uptake system localized to the nuclear envelope (42).
Because the NS protease is apparently localized to the nuclear envelope
as well, and we presented evidence previously that nuclear
Ca2+ uptake promotes endonuclease activation (27), this
activity of BCL-2 may account for the inhibition of protease and
nuclease activation observed. Alternatively, because recent work
demonstrated that the nuclear Ca2+ pool regulates transport
of large (>10 kDa) polypeptides through nuclear pores (58), it is also
possible that BCL-2 exerts its effects on nuclei by blocking
translocation of certain cytosolic proteins (i.e. p53, Myc,
ICE homologs, DNase I) that may cooperate with the NS protease to
promote lamin/histone cleavage and DNA fragmentation. These
possibilities are not mutually exclusive, and both are under
investigation at present.
An important question raised by this study concerns why specific
inhibitors of either the ICE family or the NS protease are capable of
inhibiting lamin B1 degradation and DNA fragmentation in
whole thymocytes, whereas only the latter prevent these changes in
isolated nuclei supplemented with Ca2+. It is possible that
the ICE family is involved in promoting the Ca2+
alterations that trigger nuclear NS protease activation or that the
pathways of apoptosis triggered in thymocytes by glucocorticoids,
thapsigargin, and anti-T cell receptor antibodies in thymocytes are
actually initiated within the nucleus. The latter would have important
implications for current thinking concerning the location of the
apoptotic effector machinery in general, as the results obtained with
cytoplasmic apoptosis-promoting extracts and enucleated cells (59, 60)
imply that all of the important biochemical alterations tied to
commitment to cell death occur in the cytoplasm. Both of these
explanations for the likely interrelationship between the ICE family
and the NS protease are testable hypotheses that are under
investigation at present.
FOOTNOTES
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Cell
Biology-173, The University of Texas M. D. Anderson Cancer Center,
1515 Holcombe Blvd. Houston, TX 77030. Tel.: 713-792-8591; Fax:
713-792-8747; E-mail: David_McConkey{at}isqm.mda.uth.tmc.edu.
1
The abbreviations used are: kb, kilobase(s);
ICE, interleukin 1 -converting enzyme; NS, nuclear scaffold; FIGE,
field-inversion gel electrophoresis; TLCK,
N -p-tosyl-L-lysine
chloromethyl ketone; TPCK, tosylphenylalanyl chloromethyl ketone; ATA,
aurintricarboxylic acid.
REFERENCES
-
Wyllie, A. H.,
Kerr, J. F. R.,
Currie, A. R.
(1980)
Int. Rev. Cytol.
68,
251-305
[Medline]
[Order article via Infotrieve]
-
Thompson, C. B.
(1995)
Science
267,
1456-1462
[Abstract/Free Full Text]
-
Raff, M. C.
(1992)
Nature
356,
397-400
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hengartner, M. O.,
Horvitz, H. R.
(1994)
Curr. Opin. Genet. & Dev.
4,
581-586
[CrossRef][Medline]
[Order article via Infotrieve]
-
Yuan, J.,
Shaham, S.,
Ledoux, S.,
Ellis, H. M.,
Horvitz, H. R.
(1993)
Cell
75,
641-652
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wang, L.,
Miura, M.,
Bergeron, L.,
Zhu, H.,
Yuan, J.
(1994)
Cell
78,
739-750
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chow, S. C.,
Weis, M.,
Kass, G. E. N.,
Holmstrom, T. H.,
Eriksson, J.
E.,
Orrenius, S.
(1995)
FEBS Lett.
364,
134-138
[CrossRef][Medline]
[Order article via Infotrieve]
-
Enari, M.,
Hug, H.,
Nagata, S.
(1995)
Nature
375,
78-81
[CrossRef][Medline]
[Order article via Infotrieve]
-
Los, M.,
Van de Craen, M.,
Penning, L. C.,
Schenk, H.,
Westendorp, M.,
Baeuerle, P. A.,
Droge, W.,
Krammer, P. H.,
Fiers, W.,
Schulze-Osthoff, K.
(1995)
Nature
375,
81-83
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kaufmann, S. H.
(1989)
Cancer Res.
49,
5870-5878
[Abstract/Free Full Text]
-
Neamati, N.,
Fernandez, A.,
Wright, S.,
Kiefer, J.,
McConkey, D. J.
(1995)
J. Immunol.
154,
3788-3795
[Abstract]
-
Oberhammer, F. A.,
Hochegger, K.,
Froschl, G.,
Tiefenbacher, R.,
Pavelka, M.
(1994)
J. Cell Biol.
1267,
827-837
-
Ucker, D. S.,
Obermiller, P. S.,
Eckhart, W.,
Apgar, J. R.,
Berger, N.
A.,
Meyers, J.
(1992)
Mol. Cell. Biol.
12,
3060-3069
[Abstract/Free Full Text]
-
Lazebnik, Y. A.,
Cole, S.,
Cooke, C. A.,
Nelson, W. G.,
Earnshaw, W. C.
(1993)
J. Cell Biol.
123,
7-22
[Abstract/Free Full Text]
-
Lazebnik, Y. A.,
Takahashi, A.,
Moir, R. D.,
Goldman, R. D.,
Poirier, G. G.,
Kaufmann, S. H.,
Earnshaw, W. C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9042-9046
[Abstract/Free Full Text]
-
Clawson, G. A.,
Norbeck, L. L.,
Hatem, C. L.,
Rhodes, C.,
Amiri, P.,
McKerrow, J. H.,
Patierno, S. R.,
Fiskum, G.
(1992)
Cell Growth & Differ.
3,
827-838
[Abstract]
-
Cohen, G. M.,
Sun, X. M.,
Fearnhead, H.,
MacFarlane, M.,
Brown, D. G.,
Snowden, R. T.,
Dinsdale, D.
(1994)
J. Immunol.
153,
507-516
[Abstract]
-
Filipski, J.,
Leblanc, J.,
Youdale, T.,
Sikorska, M.,
Walker, P. R.
(1990)
EMBO J.
9,
1319-1327
[Medline]
[Order article via Infotrieve]
-
Oberhammer, F.,
Wilson, J. W.,
Dive, C.,
Morris, I. D.,
Hickman, J. A.,
Wakeling, A. E.,
Walker, P. R.,
Sikorska, M.
(1993)
EMBO J.
12,
3679-3684
[Medline]
[Order article via Infotrieve]
-
Sun, X.-M.,
Cohen, G. M.
(1994)
J. Biol. Chem.
269,
14857-14860
[Abstract/Free Full Text]
-
Huang, P.,
Robertson, L. E.,
Wright, S.,
Plunkett, W.
(1995)
Clin. Cancer Res.
1,
1005-1013
[Abstract]
-
McConkey, D. J.,
Nicotera, P.,
Orrenius, S.
(1994)
Immunol. Rev.
142,
343-363
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hewish, D. R.,
Burgoyne, L. A.
(1973)
Biochem. Biophys. Res. Commun.
52,
504-510
[CrossRef][Medline]
[Order article via Infotrieve]
-
Vanderbilt, J. N.,
Bloom, K. S.,
Anderson, J. N.
(1982)
J. Biol. Chem.
257,
13009-13017
[Free Full Text]
-
Wyllie, A. H.,
Morris, R. G.,
Smith, A. L.,
Dunlop, D.
(1984)
J. Pathol.
142,
67-77
[CrossRef][Medline]
[Order article via Infotrieve]
-
Cohen, J. J.,
Duke, R. C.
(1984)
J. Immunol.
132,
38-42
[Abstract]
-
Jones, D. P.,
McConkey, D. J.,
Nicotera, P.,
Orrenius, S.
(1989)
J. Biol. Chem.
264,
6398-6403
[Abstract/Free Full Text]
-
Fernandez, A.,
Fosdick, L. J.,
Marin, M. C.,
Diaz, C.,
McDonnell, T.
J.,
Ananthaswamy, H. N.,
McConkey, D. J.
(1995)
Oncogene
10,
769-774
[Medline]
[Order article via Infotrieve]
-
McConkey, D. J.,
Nicotera, P.,
Hartzell, P.,
Bellomo, G.,
Wyllie, A.
H.,
Orrenius, S.
(1989)
Arch. Biochem. Biophys.
269,
365-370
[CrossRef][Medline]
[Order article via Infotrieve]
-
Burton, K.
(1956)
Biochem. J.
62,
315-323
[Medline]
[Order article via Infotrieve]
-
Fearnhead, H. O.,
Dinsdale, D.,
Cohen, G. M.
(1995)
FEBS Lett.
375,
283-288
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhivotovsky, B.,
Gahm, A.,
Andarcrona, M.,
Nicotera, P.,
Orrenius, S.
(1995)
Exp. Cell Res.
221,
404-412
[CrossRef][Medline]
[Order article via Infotrieve]
-
Martin, S. J.,
Newmeyer, D. D.,
Mathias, S.,
Farschon, D. M.,
Wang, H.
G.,
Reed, J. C.,
Kolesnick, R. N.,
Green, D. R.
(1995)
EMBO J.
14,
5191-5200
[Medline]
[Order article via Infotrieve]
-
Enari, M.,
Hase, A.,
Nagata, S.
(1995)
EMBO J.
14,
5201-5208
[Medline]
[Order article via Infotrieve]
-
Sun, D. Y.,
Jiang, S.,
Zheng, L.-M.,
Ojcius, D. M.,
Young, J. D.-E.
(1994)
J. Exp. Med.
179,
559-568
[Abstract/Free Full Text]
-
Zhivotovsky, B.,
Wade, D.,
Gahm, A.,
Orrenius, S.,
Nicotera, P.
(1994)
FEBS Lett.
351,
150-154
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nicholson, D. W.,
Ali, A.,
Thornberry, N. A.,
Vaillancourt, J. P.,
Ding, C. K.,
Gallant, M.,
Gareau, Y.,
Griffin, P. R.,
Labelle, M.,
Lazebnik, Y. A.,
Munday, N. A.,
Raju, S. M.,
Smulson, M. E.,
Yamin, T.-T.,
Yu, V. L.,
Miller, D. K.
(1995)
Nature
376,
37-43
[CrossRef][Medline]
[Order article via Infotrieve]
-
McConkey, D. J.,
Hartzell, P.,
Nicotera, P.,
Orrenius, S.
(1989)
FASEB J.
3,
1843-1849
[Abstract]
-
Dowd, D. R.,
MacDonald, P. N.,
Komm, B. S.,
Haussler, M. R.,
Miesfeld, R.
(1991)
J. Biol. Chem.
266,
18423-18426
[Abstract/Free Full Text]
-
Madsen, K. R.,
Fiskum, G.,
Clawson, G. A.
(1990)
Exp. Cell Res.
187,
343-345
[CrossRef][Medline]
[Order article via Infotrieve]
-
deJong, D.,
Prins, F. A.,
Mason, D. Y.,
Reed, J. C.,
Ommen, G. B.,
Kluin, P. M.
(1994)
Cancer Res.
54,
256-260
[Abstract/Free Full Text]
-
Marin, M. C.,
Fernandez, A.,
Bick, R. J.,
Brisbay, S.,
Buja, M.,
Snuggs, M.,
McConkey, D. J.,
Eschenbach, A. C.,
Keating, M. J.,
McDonnell, T. J.
(1996)
Oncogene
12,
2259-2260
[Medline]
[Order article via Infotrieve]
-
Ashwell, J. D.,
Longo, D. L.,
Bridges, S. H.
(1987)
Science
237,
61-64
[Abstract/Free Full Text]
-
Khodarev, N. N.,
Ashwell, J. D.
(1996)
J. Immunol.
156,
922-931
[Abstract]
-
Staroselsky, A. H.,
Pathak, S.,
Chernajovsky, Y.,
Tucker, S. L.,
Fidler, I. J.
(1991)
Cancer Res.
51,
6292-6298
[Abstract/Free Full Text]
-
Fearnhead, H. O.,
Rivett, A. J.,
Dinsdale, D.,
Cohen, G. M.
(1995)
FEBS Lett.
357,
242-246
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gaido, M. L.,
Cidlowski, J. A.
(1991)
J. Biol. Chem.
266,
18580-18585
[Abstract/Free Full Text]
-
Wyllie, A. H.,
Arends, M. J.,
Morris, R. G.,
Walker, S. W.,
Evan, G.
(1992)
Semin. Immunol.
4,
389-397
[Medline]
[Order article via Infotrieve]
-
Twigg, J.,
Patel, R.,
Whitaker, M.
(1988)
Nature
332,
366-369
[CrossRef][Medline]
[Order article via Infotrieve]
-
Steinhardt, R. A.,
Alderton, J.
(1988)
Nature
332,
364-366
[CrossRef][Medline]
[Order article via Infotrieve]
-
Enomoto, K.,
Oyamada, M.,
Sato, M.,
Asakura, S.,
Oyamada, Y.,
Dempo, K.,
Kaneko, M.,
Mori, M.
(1987)
Carcinogenesis
8,
1933-1934
[Abstract/Free Full Text]
-
Kaneko, A.,
Enomoto, K.,
Oyamada, M.,
Sawada, N.,
Dempo, K.,
Mori, M.
(1986)
J. Natl. Cancer Inst.
77,
121-125
-
Clawson, G. A.,
Norbeck, L. L.,
Wise, J. P.,
Patierno, S. R.
(1993)
Cell Growth & Differ.
4,
589-594
[Abstract]
-
Harrington, E. A.,
Fanidi, A.,
Evan, G. I.
(1994)
Curr. Opin. Genet. & Dev.
4,
120-129
[CrossRef][Medline]
[Order article via Infotrieve]
-
Shi, L.,
Nishioka, W. K.,
Th'ng, J.,
Bradbury, E. M.,
Litchfield, D.
W.,
Greenberg, A. H.
(1994)
Science
263,
1143-1145
[Abstract/Free Full Text]
-
Schwartz, L. M.,
Smith, S. W.,
Jones, M. E. E.,
Osborne, B. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
980-984
[Abstract/Free Full Text]
-
Delic, J.,
Morange, M.,
Magdelenat, H.
(1993)
Mol. Cell. Biol.
13,
4875-4883
[Abstract/Free Full Text]
-
Stehno-Bittel, L.,
Perez-Terzic, C.,
Clapham, D. E.
(1995)
Science
270,
1835-1838
[Abstract/Free Full Text]
-
Schulze-Osthoff, K.,
Walczak, H.,
Droge, W.,
Krammer, P. H.
(1994)
J. Cell Biol.
127,
15-20
[Abstract/Free Full Text]
-
Jacobson, M. D.,
Burne, J. F.,
Raff, M. C.
(1994)
EMBO J.
13,
1899-1910
[Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Jayanthi, X. Deng, B. Ladenheim, M. T. McCoy, A. Cluster, N.-s. Cai, and J. L. Cadet
Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis
PNAS,
January 18, 2005;
102(3):
868 - 873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kashio, K. Nakamura, M. J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, and M. Hirashima
Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 Pathway
J. Immunol.,
April 1, 2003;
170(7):
3631 - 3636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhang, P. J. Beresford, A. H. Greenberg, and J. Lieberman
Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis
PNAS,
April 25, 2001;
(2001)
101329598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. B. Moon, P. C. Turner, and R. W. Moyer
SPI-1-Dependent Host Range of Rabbitpox Virus and Complex Formation with Cathepsin G Is Associated with Serpin Motifs
J. Virol.,
November 1, 1999;
73(11):
8999 - 9010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gong, Q. Chen, B. Endlich, S. Mazumder, and A. Almasan
Ionizing Radiation-induced, Bax-mediated Cell Death Is Dependent on Activation of Cysteine and Serine Proteases
Cell Growth Differ.,
July 1, 1999;
10(7):
491 - 502.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Juin, M. Pelletier, L. Oliver, K. Tremblais, M. Gregoire, K. Meflah, and F. M. Vallette
Induction of a Caspase-3-like Activity by Calcium in Normal Cytosolic Extracts Triggers Nuclear Apoptosis in a Cell-free System
J. Biol. Chem.,
July 10, 1998;
273(28):
17559 - 17564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dallaporta, T. Hirsch, S. A. Susin, N. Zamzami, N. Larochette, C. Brenner, I. Marzo, and G. Kroemer
Potassium Leakage During the Apoptotic Degradation Phase
J. Immunol.,
June 1, 1998;
160(11):
5605 - 5615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shimizu, C.-X. Cao, R.-G. Shao, and Y. Pommier
Lamin B Phosphorylation by Protein Kinase Calpha and Proteolysis during Apoptosis in Human Leukemia HL60 Cells
J. Biol. Chem.,
April 10, 1998;
273(15):
8669 - 8674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Distelhorst and G. Dubyak
Role of Calcium in Glucocorticosteroid-Induced Apoptosis of Thymocytes and Lymphoma Cells: Resurrection of Old Theories by New Findings
Blood,
February 1, 1998;
91(3):
731 - 734.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chandra, J. Gilbreath, E. J Freireich, K.-O. Kliche, M. Andreeff, M. Keating, and D. J. McConkey
Protease Activation Is Required for Glucocorticoid-Induced Apoptosis in Chronic Lymphocytic Leukemic Lymphocytes
Blood,
November 1, 1997;
90(9):
3673 - 3681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. McConkey and S Orrenius
Signal transduction pathways in apoptosis
Stem Cells,
November 1, 1996;
14(6):
619 - 631.
[Abstract]
|
 |
|

|
 |

|
 |
 
D. Zhang, P. J. Beresford, A. H. Greenberg, and J. Lieberman
Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis
PNAS,
May 8, 2001;
98(10):
5746 - 5751.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|